Adorján Aszalós

1.4k total citations
65 papers, 1.2k citations indexed

About

Adorján Aszalós is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Adorján Aszalós has authored 65 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 21 papers in Oncology and 12 papers in Pharmacology. Recurrent topics in Adorján Aszalós's work include Drug Transport and Resistance Mechanisms (16 papers), Pharmacological Effects and Toxicity Studies (9 papers) and Signaling Pathways in Disease (7 papers). Adorján Aszalós is often cited by papers focused on Drug Transport and Resistance Mechanisms (16 papers), Pharmacological Effects and Toxicity Studies (9 papers) and Signaling Pathways in Disease (7 papers). Adorján Aszalós collaborates with scholars based in United States, Hungary and Malaysia. Adorján Aszalós's co-authors include Michael M. Gottesman, James L. Weaver, Jun‐Jie Yin, Sándor Damjanovich, Xing‐Jie Liang, Ronald M. Stroshane, Ding‐Wu Shen, P. Scott Pine, Margit Balázs and Sally A. Mulhern and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Adorján Aszalós

64 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adorján Aszalós United States 20 556 401 155 140 132 65 1.2k
Werner Rubas United States 18 613 1.1× 615 1.5× 72 0.5× 94 0.7× 149 1.1× 34 1.8k
Harold E. Selick United States 11 833 1.5× 408 1.0× 171 1.1× 80 0.6× 74 0.6× 13 1.8k
Lawrence W. Anderson United States 23 728 1.3× 351 0.9× 88 0.6× 46 0.3× 73 0.6× 57 1.5k
Tom Verhaeghe Belgium 24 652 1.2× 215 0.5× 185 1.2× 235 1.7× 91 0.7× 76 1.4k
Alex Buko United States 18 832 1.5× 257 0.6× 217 1.4× 283 2.0× 95 0.7× 29 2.0k
Pradip K. Bhatnagar United States 20 715 1.3× 281 0.7× 153 1.0× 94 0.7× 31 0.2× 54 1.5k
W N Hait United States 21 1.4k 2.5× 1.2k 2.9× 189 1.2× 194 1.4× 285 2.2× 40 2.3k
Ziping Yang United States 21 944 1.7× 455 1.1× 112 0.7× 54 0.4× 185 1.4× 45 1.7k
Chutima Srimaroeng Thailand 15 1.2k 2.2× 384 1.0× 64 0.4× 176 1.3× 154 1.2× 30 2.2k
Richard Svensson Sweden 18 491 0.9× 184 0.5× 210 1.4× 92 0.7× 69 0.5× 42 1.1k

Countries citing papers authored by Adorján Aszalós

Since Specialization
Citations

This map shows the geographic impact of Adorján Aszalós's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adorján Aszalós with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adorján Aszalós more than expected).

Fields of papers citing papers by Adorján Aszalós

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adorján Aszalós. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adorján Aszalós. The network helps show where Adorján Aszalós may publish in the future.

Co-authorship network of co-authors of Adorján Aszalós

This figure shows the co-authorship network connecting the top 25 collaborators of Adorján Aszalós. A scholar is included among the top collaborators of Adorján Aszalós based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adorján Aszalós. Adorján Aszalós is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aszalós, Adorján & Barbara J. Taylor. (2009). Flow Cytometric Evaluation of Multidrug Resistance Proteins. Methods in molecular biology. 596. 123–139. 2 indexed citations
2.
Aszalós, Adorján. (2008). Role of ATP-Binding Cassette (ABC) Transporters in Interactions Between Natural Products and Drugs. Current Drug Metabolism. 9(10). 1010–1018. 44 indexed citations
3.
Liang, Xing‐Jie, Jun‐Jie Yin, Barbara J. Taylor, et al.. (2008). Disruption of microfilaments by cytochalasin B decreases accumulation of cisplatin in human epidermal carcinoma and liver carcinoma cell lines. Cancer Chemotherapy and Pharmacology. 62(6). 977–984. 7 indexed citations
4.
Aszalós, Adorján. (2007). Drug–drug interactions affected by the transporter protein, P-glycoprotein (ABCB1, MDR1). Drug Discovery Today. 12(19-20). 833–837. 29 indexed citations
5.
Liang, Xing‐Jie, Carol Cardarelli, Barbara J. Taylor, et al.. (2003). P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential.. PubMed. 63(12). 3084–91. 56 indexed citations
6.
Aszalós, Adorján. (2002). Specific cell-signal targets for cancer chemotherapy. Archives of Pharmacal Research. 25(1). 1–10. 2 indexed citations
7.
Hastings, Kenneth L., Chang‐Ho Ahn, Adorján Aszalós, et al.. (1997). Considerations in Assessing the Immunotoxic Potential of Investigational Drugs. Drug Information Journal. 31(4). 1357–1361. 5 indexed citations
8.
Aszalós, Adorján, et al.. (1997). Molecular events as targets of anticancer drug therapy. Pathology & Oncology Research. 3(2). 147–158. 1 indexed citations
9.
Aszalós, Adorján, P. Scott Pine, Ramesh C. Pandey, & Michael M. Gottesman. (1995). Behavior of N-acylated daunorubicins in MDR1 gene transfected and parental cells. Biochemical Pharmacology. 50(6). 889–892. 5 indexed citations
10.
Szabó, Gábor, P. Scott Pine, James L. Weaver, Patricia E. Rao, & Adorján Aszalós. (1994). The L‐selectin (Leu8) molecule is associated with the TcR/CD3 receptor; fluorescence energy transfer measurements on live cells. Immunology and Cell Biology. 72(4). 319–325. 7 indexed citations
11.
Weaver, James L., et al.. (1992). Prevention of binding of rgp120 by anti-HIV active tannins. Biochemical Pharmacology. 43(11). 2479–2480. 32 indexed citations
12.
Balint, Elisabeth Maria, et al.. (1992). Cytoskeletal Modulation of Plasma Membrane Events Induced by Interferon-α. Journal of Interferon Research. 12(4). 249–255. 5 indexed citations
13.
Weaver, James L., Adorján Aszalós, Patricia V. Schoenlein, et al.. (1991). Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine 123 in multidrug-resistant cells. Experimental Cell Research. 196(2). 323–329. 68 indexed citations
14.
Aszalós, Adorján. (1991). Cyclosporin elicits a non-responsive state and a shift in K+ fluxes in the early phase of activation of human lymphocytes with anti-CD3. European Journal of Pharmacology. 205(2). 125–133. 3 indexed citations
15.
Weaver, James L., et al.. (1991). Comparison of theIn Vitroand Biophysical Effects of Cyclosporine a, FK-506, and Mycophenolic Acid on Human Peripheral Blood Lymphocytes. Immunopharmacology and Immunotoxicology. 13(4). 563–576. 15 indexed citations
16.
Csermely, Péter, et al.. (1990). Protein Kinase C Is Involved in the Early Signals of Interferon-α But Not of Interferon-γ in U937 Cells. Journal of Interferon Research. 10(6). 605–611. 14 indexed citations
17.
Gergely, P & Adorján Aszalós. (1990). Effect of cyclosporin A on the anti-CD3 antibody- and concanavalin A-induced activation and membrane potential of human T lymphocytes. Immunopharmacology. 20(3). 191–199. 4 indexed citations
18.
Weaver, James L., et al.. (1990). Aurin tricarboxylic acid, the anti-AIDS compound, prevents the binding of interferon-α to its receptor. Biochemical and Biophysical Research Communications. 172(3). 1298–1303. 16 indexed citations
19.
Balint, Elisabeth Maria, Adorján Aszalós, & Philip M. Grimley. (1988). Alpha interferon accelerates lateral diffusion of Daudi cell surface differentiation antigens: Measurement by fluorescence redistribution after photobleaching. Biochemical and Biophysical Research Communications. 157(2). 808–815. 7 indexed citations
20.
Aszalós, Adorján, et al.. (1979). Biological and physio-chemical properties of some N-acyl-daunorubicin derivatives. Biochemical Pharmacology. 28(2). 335–337. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Werner Rubas Breakdown of academic impact, for papers by Harold E. Selick Breakdown of academic impact, for papers by Lawrence W. Anderson Breakdown of academic impact, for papers by Tom Verhaeghe Breakdown of academic impact, for papers by Alex Buko Breakdown of academic impact, for papers by Pradip K. Bhatnagar Breakdown of academic impact, for papers by W N Hait Breakdown of academic impact, for papers by Ziping Yang Breakdown of academic impact, for papers by Chutima Srimaroeng Breakdown of academic impact, for papers by Richard Svensson
Rankless by CCL
2026